Song Ong

Dr. Song Ong


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2021 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
MLMichelle Lubetzky
Michelle Lubetzky
ETEkamol Tantisattamo
Ekamol Tantisattamo
MMMiklos Z. Molnar
Miklos Z. Molnar
KLKrista L Lentine
Krista L Lentine
ABArpita Basu
Arpita Basu
TATarek Alhamad
Tarek Alhamad
The return to dialysis after allograft failure is associated with increased morbidity and mortality. This transition is made more complex by the rising numbers of patients who seek repeat transplantation and therefore may have indications for remaining on low levels of immunosuppression, despite the potential increased morbidity. Management strategies vary across providers, driven by limited data on how to transition off immunosuppression as the allograft fails and a paucity of randomized controlled trials to support one approach over another. In this review we summarize the current data available for management and care of the failing allograft. Additionally, we discuss a suggested plan for immunosuppression weaning based upon availability of re-transplantation and residual allograft function. We propose a shared-care model in which there is improved coordination between transplant providers and general nephrologists so that immunosuppression management and preparation for renal replacement therapy and/or repeat transplantation can be conducted with the goal of improved outcomes and decreased morbidity in this vulnerable patient group.

1 April 2015 in Transplantation Reviews
Verified
Journal Article
Closed access
SOSong Ong
Song Ong
RMRoslyn B. Mannon
Roslyn B. Mannon

17 September 2023 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
NMNaoka Murakami
Naoka Murakami
ARAmanda J. Reich
Amanda J. Reich
KHKatherine He
Katherine He
SGSamantha L. Gelfand
Samantha L. Gelfand
RLRichard E. Leiter
Richard E. Leiter
TATarek Alhamad
Tarek Alhamad

14 October 2022 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
RWRongzhi Wang
Rongzhi Wang
FSFaaiz Saad
Faaiz Saad
MMM. Chandler McLeod
M. Chandler McLeod
CKClifton Kew
Clifton Kew
GAGaurav Agarwal
Gaurav Agarwal
SOSong Ong
Song Ong

6 February 2024 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
NSNeeraj Singh
Neeraj Singh
PAPrince Mohan Anand
Prince Mohan Anand
GGGaurav Gupta
Gaurav Gupta
DSDeirdre Sawinski
Deirdre Sawinski
OFOren Fix
Oren Fix
RBRoy Bloom
Roy Bloom
Kidney transplant is not only the best treatment for patients with advanced kidney disease but it also reduces health care expenditure. The management of transplant patients is complex as they require special care by transplant nephrologists who have expertise in assessing transplant candidates, understand immunology and organ rejection, have familiarity with perioperative complications, and have the ability to manage the long-term effects of chronic immunosuppression. This skill set at the intersection of multiple disciplines necessitates additional training in Transplant Nephrology. Currently, there are more than 250,000 patients with a functioning kidney allograft and over 100,000 waitlisted patients awaiting kidney transplant, with a burgeoning number added to the kidney transplant wait list every year. In 2022, more than 40,000 patients were added to the kidney wait list and more than 25,000 received a kidney transplant. The Advancing American Kidney Health Initiative, passed in 2019, is aiming to double the number of kidney transplants by 2030 creating a need for additional transplant nephrologists to help care for them. Over the past decade, there has been a decline in the Nephrology—as well Transplant Nephrology—workforce due to a multitude of reasons. The American Society of Transplantation Kidney Pancreas Community of Practice created a workgroup to discuss the Transplant Nephrology workforce shortage. In this article, we discuss the scope of the problem and how the Accreditation Council for Graduate Medical Education recognition of Transplant Nephrology Fellowship could at least partly mitigate the Transplant Nephrology work force crisis.

12 November 2020 in Current Opinion in Nephrology and Hypertension
Verified
Journal Article
Closed access
SOSong Ong
Song Ong
CRConnie M. Rhee
Connie M. Rhee
Purpose of review: Posttransplant diabetes mellitus (PTDM) is a prevalent complication in kidney transplant recipients, and has been associated with worse short-term and long-term outcomes. Recent findings: While hyperglycemia is frequently seen in the early posttransplant period because of surgical stress, infection, and use of high-dose steroids, the diagnosis of PTDM should be established after patients are clinically stable and on stable maintenance immunosuppression. In the early posttransplant period, hyperglycemia is typically treated with insulin, and pilot data have suggested potential benefit of lower vs. higher glycemic targets in this setting. Growing data indicate lifestyle modifications, including dietary interventions, physical activity, and mitigation of obesity, are associated with improved posttransplant outcomes. While there are limited data to support a first-line antidiabetic medication for PTDM, more established pharmacotherapies such as sulfonylureas, meglitinides, and dipetidyl peptidase IV inhibitors are commonly used. Given recent trials showing the benefits of sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists upon kidney outcomes in nontransplant patients, further study of these agents specifically in kidney transplant recipients are urgently needed. Summary: Increasing evidence supports a multidisciplinary approach, including lifestyle modification, obesity treatment, judicious immunosuppression selection, and careful utilization of novel antidiabetic therapies in PTDM patients.